With 0.21 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.53 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $6.73 whereas the lowest price it dropped to was $6.58. The 52-week range on SIGA shows that it touched its highest point at $11.62 and its lowest point at $4.48 during that stretch. It currently has a 1-year price target of $11.00. SIGA paid its most recent dividend on 1745884800, while the ex-dividend date for that was 1745884800. Beta for the stock currently stands at 0.94.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SIGA was up-trending over the past week, with a rise of 1.98%, but this was up by 7.90% over a month. Three-month performance surged to 34.33% while six-month performance rose 24.80%. The stock gained 22.93% in the past year, while it has lost -2.14% so far this year. A look at the trailing 12-month EPS for SIGA yields 0.68 with Next year EPS estimates of 1.70.
Float and Shares Shorts:
At present, 71.44 million SIGA shares are outstanding with a float of 40.45 million shares on hand for trading. On 2025-06-13, short shares totaled 3.06 million, which was 427.99999999999994 higher than short shares on 1747267200. In addition to Dr. Diem Nguyen M.B.A., Ph.D. as the firm’s CEO & Director, Mr. Daniel J. Luckshire CPA, M.B.A. serves as its Executive VP, CFO & Secretary.
Institutional Ownership:
Through their ownership of 0.51669997 of SIGA’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2025-03-31, SIGA reported revenue of $7040815.0 and operating income of -$2255398.0. The EBITDA in the recently reported quarter was -$2120090.0 and diluted EPS was -$0.01.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. Analysts have provided yearly estimates in a range of $1.05 being high and $1.05 being low. For SIGA, this leads to a yearly average estimate of $1.05.
